Juha Rinne
jurin@utu.fi +358 50 441 2400 |
Publications
- Depressive Symptoms and Amyloid Pathology (2025)
- JAMA Psychiatry
(A1 Refereed original research article in a scientific journal) - Enhancing dementia prediction: A 19-year validation of the CAIDE risk score with insulin resistance and APOE ε4 integration in a population-based cohort (2025)
- The Journal of Prevention of Alzheimer's Disease
(A1 Refereed original research article in a scientific journal) - Impaired Gait, Postural Instability, and Rigidity in Relation to CB1 Receptor Availability in Parkinson's Disease (2025)
- Movement Disorders
(A1 Refereed original research article in a scientific journal) - Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study (2025)
- Digestive and Liver Disease
(A1 Refereed original research article in a scientific journal) - Neuroinflammation in Parkinson’s disease : A study with [11C]PBR28 PET and cerebrospinal fluid markers (2025)
- Parkinsonism and Related Disorders
(A1 Refereed original research article in a scientific journal) - Progression of Amyloid Accumulation in Late Adulthood Among People With Childhood-Onset Epilepsy (2025)
- Neurology
(A1 Refereed original research article in a scientific journal) - The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions (2025)
- Journal of Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort (2024)
- NeuroImage: Clinical
(A1 Refereed original research article in a scientific journal) - Alzheimerin taudin lääkehoito (2024) Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
(D2 Article in a professional compilation book) - Alzheimerin tauti sairautena (2024) Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
(D2 Article in a professional compilation book) - Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial (2024)
- Alzheimer's and Dementia
(A1 Refereed original research article in a scientific journal) - Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial (Nature Medicine, (2023), 29, 6, (1437-1447), 10.1038/s41591-023-02326-3) (2024)
- Nature Medicine
(Other publication) - Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly (2024)
- Alzheimer's Research and Therapy
(A1 Refereed original research article in a scientific journal) - Bone marrow metabolism is affected by body weight and response to exercise training varies according to anatomical location (2024)
- Diabetes, Obesity and Metabolism
(A1 Refereed original research article in a scientific journal) - Brain amyloid load, subjective memory complaints, and cognitive trajectories in older individuals at risk for dementia (2024)
- European Journal of Neurology
(A1 Refereed original research article in a scientific journal) - Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET (2024)
- Neurobiology of Disease
(A1 Refereed original research article in a scientific journal) - Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)
- EJNMMI Research
(Other publication) - Effects of Obesity and Exercise on Hepatic and Pancreatic Lipid Content and Glucose Metabolism : PET Studies in Twins Discordant for BMI (2024)
- Biomolecules
(A1 Refereed original research article in a scientific journal) - Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes (2024)
- Alzheimer's and Dementia
(A1 Refereed original research article in a scientific journal) - Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (2024)
- EJNMMI Research
(A1 Refereed original research article in a scientific journal)